<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34040615</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>06</Month>
        <Day>07</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>06</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">1664-3224</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>12</Volume>
            <PubDate>
              <Year>2021</Year>
            </PubDate>
          </JournalIssue>
          <Title>Frontiers in immunology</Title>
          <ISOAbbreviation>Front Immunol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms.</ArticleTitle>
        <Pagination>
          <StartPage>674922</StartPage>
          <MedlinePgn>674922</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">674922</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2021.674922</ELocationID>
        <Abstract>
          <AbstractText>Since December 2019, the world has been facing an outbreak of a new disease called coronavirus disease 2019 (COVID-19). The COVID-19 pandemic is caused by a novel beta-coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 infection mainly affects the respiratory system. Recently, there have been some reports of extra-respiratory symptoms such as neurological manifestations in COVID-19. According to the increasing reports of Guillain-Barré syndrome following COVID-19, we mainly focused on SARS-CoV-2 infection and Guillain-Barré syndrome in this review. We tried to explain the possibility of a relationship between SARS-CoV-2 infection and Guillain-Barré syndrome and potential pathogenic mechanisms based on current and past knowledge.</AbstractText>
          <CopyrightInformation>Copyright © 2021 Shoraka, Ferreira, Mohebbi and Ghaemi.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Shoraka</LastName>
            <ForeName>Shahrzad</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology and Microbial Biotechnology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ferreira</LastName>
            <ForeName>Maria Lucia Brito</ForeName>
            <Initials>MLB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Hospital da Restauração, Recife, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mohebbi</LastName>
            <ForeName>Seyed Reza</ForeName>
            <Initials>SR</Initials>
            <AffiliationInfo>
              <Affiliation>Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ghaemi</LastName>
            <ForeName>Amir</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Virology, Pasteur Institute of Iran, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>05</Month>
          <Day>10</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Front Immunol</MedlineTA>
        <NlmUniqueID>101560960</NlmUniqueID>
        <ISSNLinking>1664-3224</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020275" MajorTopicYN="N">Guillain-Barre Syndrome</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009422" MajorTopicYN="N">Nervous System Diseases</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
          <QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">COVID-19</Keyword>
        <Keyword MajorTopicYN="N">Coronavirus</Keyword>
        <Keyword MajorTopicYN="N">Guillain-Barré syndrome</Keyword>
        <Keyword MajorTopicYN="N">Neurological manifestations</Keyword>
        <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>39</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34040615</ArticleId>
        <ArticleId IdType="pmc">PMC8141918</ArticleId>
        <ArticleId IdType="doi">10.3389/fimmu.2021.674922</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
De Wit E, Van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: Recent Insights Into Emerging Coronaviruses. Nat Rev Microbiol (2016) 14:523–34. 10.1038/nrmicro.2016.81
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrmicro.2016.81</ArticleId>
            <ArticleId IdType="pmc">PMC7097822</ArticleId>
            <ArticleId IdType="pubmed">27344959</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Harb JG, Noureldine HA, Chedid G, Eldine MN, Abdallah DA, Chedid NF, et al. . Sars, MERS and COVID-19: Clinical Manifestations and Organ-System Complications: A Mini Review. Pathog Dis (2020) 78:1–7. 10.1093/femspd/ftaa033
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/femspd/ftaa033</ArticleId>
            <ArticleId IdType="pmc">PMC7454523</ArticleId>
            <ArticleId IdType="pubmed">32633327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wang L, Wang Y, Ye D, Liu Q. Review of the 2019 Novel Coronavirus (SARS-CoV-2) Based on Current Evidence. Int J Antimicrob Agents (2020) 55:105948. 10.1016/j.ijantimicag.2020.105948
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijantimicag.2020.105948</ArticleId>
            <ArticleId IdType="pmc">PMC7156162</ArticleId>
            <ArticleId IdType="pubmed">32201353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bridwell R, Long B, Gottlieb M. Neurologic Complications of COVID-19. Am J Emerg Med (2020) 38:1549.e3–.e7. 10.1016/j.ajem.2020.05.024
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajem.2020.05.024</ArticleId>
            <ArticleId IdType="pmc">PMC7229718</ArticleId>
            <ArticleId IdType="pubmed">32425321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kwong KCNK, Mehta PR, Shukla G, Mehta AR. COVID-19, SARS and MERS: A Neurological Perspective. J Clin Neurosci (2020) 77:13–6. 10.1016/j.jocn.2020.04.124
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jocn.2020.04.124</ArticleId>
            <ArticleId IdType="pmc">PMC7198407</ArticleId>
            <ArticleId IdType="pubmed">32417124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
He F, Deng Y, Li W. Coronavirus Disease 2019: What We Know? J Med Virol (2020) 92:719–25. 10.1002/jmv.25766
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jmv.25766</ArticleId>
            <ArticleId IdType="pmc">PMC7228340</ArticleId>
            <ArticleId IdType="pubmed">32170865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sahin AR. 2019 Novel Coronavirus (COVID-19) Outbreak: A Review of the Current Literature. Eurasian J Med Oncol (2020) 4:1–7. 10.14744/ejmo.2020.12220
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.14744/ejmo.2020.12220</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Nordvig AS, Rimmer KT, Willey JZ, Thakur KT, Boehme AK, Vargas WS, et al. . Potential Neurological Manifestations of COVID-19. Neurol: Clin Pract (2020) 11(2):e135–46. 10.1212/CPJ.0000000000000897
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/CPJ.0000000000000897</ArticleId>
            <ArticleId IdType="pmc">PMC8032406</ArticleId>
            <ArticleId IdType="pubmed">33842082</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Fehr AR, Perlman S. Coronaviruses: An Overview of Their Replication and Pathogenesis. Coronaviruses: Methods Protocols: Springer (2015) 1282. 10.1007/978-1-4939-2438-7_1
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-1-4939-2438-7_1</ArticleId>
            <ArticleId IdType="pmc">PMC4369385</ArticleId>
            <ArticleId IdType="pubmed">25720466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wassenaar TM, Zou Y. 2019_nCoV/SARS-CoV-2: Rapid Classification of Betacoronaviruses and Identification of Traditional Chinese Medicine as Potential Origin of Zoonotic Coronaviruses. Lett Appl Microbiol (2020) 70:342–8. 10.1111/lam.13285
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/lam.13285</ArticleId>
            <ArticleId IdType="pmc">PMC7165814</ArticleId>
            <ArticleId IdType="pubmed">32060933</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Li X, Geng M, Peng Y, Meng L, Lu S. Molecular Immune Pathogenesis and Diagnosis of COVID-19. J Pharm Anal (2020) 10:102–8. 10.1016/j.jpha.2020.03.001
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jpha.2020.03.001</ArticleId>
            <ArticleId IdType="pmc">PMC7104082</ArticleId>
            <ArticleId IdType="pubmed">32282863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Paules CI, Marston H, Fauc AS. Coronavirus Infections—More Than Just the Common Cold. J Am Med Assoc (2020) 323:707–8. 10.1001/jama.2020.0757
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.2020.0757</ArticleId>
            <ArticleId IdType="pubmed">31971553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Forni D, Cagliani R, Clerici M, Sironi M. Molecular Evolution of Human Coronavirus Genomes. Trends Microbiol (2017) 25:35–48. 10.1016/j.tim.2016.09.001
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tim.2016.09.001</ArticleId>
            <ArticleId IdType="pmc">PMC7111218</ArticleId>
            <ArticleId IdType="pubmed">27743750</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Phan T. Novel Coronavirus: From Discovery to Clinical Diagnostics. Infect Genet Evol (2020) 79:104211. 10.1016/j.meegid.2020.104211
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.meegid.2020.104211</ArticleId>
            <ArticleId IdType="pmc">PMC7129799</ArticleId>
            <ArticleId IdType="pubmed">32007627</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Alsaied T, Aboulhosn JA, Cotts TB, Daniels CJ, Etheridge SP, Feltes TF, et al. . Coronavirus Disease 2019 (COVID-19) Pandemic Implications in Pediatric and Adult Congenital Heart Disease. J Am Heart Assoc (2020) 9:e017224. 10.1161/JAHA.120.017224
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/JAHA.120.017224</ArticleId>
            <ArticleId IdType="pmc">PMC7429046</ArticleId>
            <ArticleId IdType="pubmed">32441586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Henry BM, Lippi G. Chronic Kidney Disease is Associated With Severe Coronavirus Disease 2019 (COVID-19) Infection. Int Urol Nephrol (2020) 52:1193–4. 10.1007/s11255-020-02451-9
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11255-020-02451-9</ArticleId>
            <ArticleId IdType="pmc">PMC7103107</ArticleId>
            <ArticleId IdType="pubmed">32222883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Xu L, Liu J, Lu M, Yang D, Zheng X. Liver Injury During Highly Pathogenic Human Coronavirus Infections. Liver Int (2020) 40:998–1004. 10.1111/liv.14435
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/liv.14435</ArticleId>
            <ArticleId IdType="pmc">PMC7228361</ArticleId>
            <ArticleId IdType="pubmed">32170806</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the Nervous System. Cell (2020) 183:16–27.e1. 10.1016/j.cell.2020.08.028
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2020.08.028</ArticleId>
            <ArticleId IdType="pmc">PMC7437501</ArticleId>
            <ArticleId IdType="pubmed">32882182</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. . A New Coronavirus Associated With Human Respiratory Disease in China. Nature (2020) 579:265–9. 10.1038/s41586-020-2008-3
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41586-020-2008-3</ArticleId>
            <ArticleId IdType="pmc">PMC7094943</ArticleId>
            <ArticleId IdType="pubmed">32015508</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. . A Pneumonia Outbreak Associated With a New Coronavirus of Probable Bat Origin. Nature (2020) 579:270–3. 10.1038/s41586-020-2012-7
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId>
            <ArticleId IdType="pmc">PMC7095418</ArticleId>
            <ArticleId IdType="pubmed">32015507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Das G, Mukherjee N, Ghosh S. Neurological Insights of COVID-19 Pandemic. ACS Chem Neurosci (2020) 11:1206–9. 10.1021/acschemneuro.0c00201
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acschemneuro.0c00201</ArticleId>
            <ArticleId IdType="pmc">PMC7179739</ArticleId>
            <ArticleId IdType="pubmed">32320211</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, et al. . Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation. Science (2020) 367:1260–3. 10.1126/science.abb2507
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.abb2507</ArticleId>
            <ArticleId IdType="pmc">PMC7164637</ArticleId>
            <ArticleId IdType="pubmed">32075877</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. . Clinical Features of Patients Infected With 2019 Novel Coronavirus in Wuhan, China. Lancet (2020) 395:497–506. 10.1016/S0140-6736(20)30183-5
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId>
            <ArticleId IdType="pmc">PMC7159299</ArticleId>
            <ArticleId IdType="pubmed">31986264</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Li YC, Bai WZ, Hashikawa T. The Neuroinvasive Potential of SARS-CoV2 may Play a Role in the Respiratory Failure of COVID-19 Patients. J Med Virol (2020) 92:552–5. 10.1002/jmv.25728
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jmv.25728</ArticleId>
            <ArticleId IdType="pmc">PMC7228394</ArticleId>
            <ArticleId IdType="pubmed">32104915</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lai CC, Ko WC, Lee PI, Jean SS, Hsueh PR. Extra-Respiratory Manifestations of COVID-19. Int J Antimicrob Agents (2020) 56:106024. 10.1016/j.ijantimicag.2020.106024
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijantimicag.2020.106024</ArticleId>
            <ArticleId IdType="pmc">PMC7243791</ArticleId>
            <ArticleId IdType="pubmed">32450197</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular Complications in COVID-19. Am J Emerg Med (2020) 38:1504–7. 10.1016/j.ajem.2020.04.048
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajem.2020.04.048</ArticleId>
            <ArticleId IdType="pmc">PMC7165109</ArticleId>
            <ArticleId IdType="pubmed">32317203</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Pei G, Zhang Z, Peng J, Liu L, Zhang C, Yu C, et al. . Renal Involvement and Early Prognosis in Patients With COVID-19 Pneumonia. J Am Soc Nephrol (2020) 31:1157–65. 10.1681/ASN.2020030276
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2020030276</ArticleId>
            <ArticleId IdType="pmc">PMC7269350</ArticleId>
            <ArticleId IdType="pubmed">32345702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Heming M, Li X, Räuber S, Mausberg AK, Börsch A-L, Hartlehnert M, et al. . Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid. Immunity (2021) 54(1):164–75.e6. 10.1016/j.immuni.2020.12.011
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2020.12.011</ArticleId>
            <ArticleId IdType="pmc">PMC7831653</ArticleId>
            <ArticleId IdType="pubmed">33382973</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cheng Q, Yang Y, Gao J. Infectivity of Human Coronavirus in the Brain. EBioMedicine (2020) 56:102799. 10.1016/j.ebiom.2020.102799
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ebiom.2020.102799</ArticleId>
            <ArticleId IdType="pmc">PMC7255711</ArticleId>
            <ArticleId IdType="pubmed">32474399</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Nersesjan V, Amiri M, Lebech A-M, Roed C, Mens H, Russell L, et al. . Central and Peripheral Nervous System Complications of COVID-19: A Prospective Tertiary Center Cohort With 3-Month Follow-Up. J Neurol (2021), 1–19. 10.1007/s00415-020-10380-x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-020-10380-x</ArticleId>
            <ArticleId IdType="pmc">PMC7803470</ArticleId>
            <ArticleId IdType="pubmed">33438076</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Perrin P, Collongues N, Baloglu S, Bedo D, Bassand X, Lavaux T, et al. . Cytokine Release Syndrome-Associated Encephalopathy in Patients With COVID-19. Eur J Neurol (2021) 28(1):248–58. 10.1111/ene.14491
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ene.14491</ArticleId>
            <ArticleId IdType="pmc">PMC7461405</ArticleId>
            <ArticleId IdType="pubmed">32853434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Espíndola OM, Brandão CO, Gomes YCP, Siqueira M, Soares CN, Lima MASD, et al. . Cerebrospinal Fluid Findings in Neurological Diseases Associated With COVID-19 and Insights Into Mechanisms of Disease Development. Int J Infect Dis (2021) 102:155–62. 10.1016/j.ijid.2020.10.044
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijid.2020.10.044</ArticleId>
            <ArticleId IdType="pmc">PMC7591319</ArticleId>
            <ArticleId IdType="pubmed">33127503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Domingues RB, Mendes-Correa MC, de Moura Leite FBV, Sabino EC, Salarini DZ, Claro I, et al. . First Case of SARS-COV-2 Sequencing in Cerebrospinal Fluid of a Patient With Suspected Demyelinating Disease. J Neurol (2020) 267:3154–6. 10.1007/s00415-020-09996-w
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-020-09996-w</ArticleId>
            <ArticleId IdType="pmc">PMC7305694</ArticleId>
            <ArticleId IdType="pubmed">32564153</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lahiri D, Ardila A. COVID-19 Pandemic: A Neurological Perspective. Cureus (2020) 12:2–7. 10.7759/cureus.7889
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7759/cureus.7889</ArticleId>
            <ArticleId IdType="pmc">PMC7255551</ArticleId>
            <ArticleId IdType="pubmed">32489743</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Desforges M, Le Coupanec A, Dubeau P, Bourgouin A, Lajoie L, Dubé M, et al. . Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? Viruses (2019) 12:1–28. 10.3390/v12010014
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/v12010014</ArticleId>
            <ArticleId IdType="pmc">PMC7020001</ArticleId>
            <ArticleId IdType="pubmed">31861926</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Verstrepen K, Baisier L, De Cauwer H. Neurological Manifestations of COVID-19, SARS and MERS. Acta Neurol Belg (2020) 120:1051–60. 10.1007/s13760-020-01412-4
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13760-020-01412-4</ArticleId>
            <ArticleId IdType="pmc">PMC7303437</ArticleId>
            <ArticleId IdType="pubmed">32562214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Rodriguez-Morales AJ, Rodriguez-Morales AG, Méndez CA, Hernández-Botero S. Tracing New Clinical Manifestations in Patients With COVID-19 in Chile and Its Potential Relationship With the SARS-CoV-2 Divergence. Curr Trop Med Rep (2020) 7:75–8. 10.1007/s40475-020-00205-2
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s40475-020-00205-2</ArticleId>
            <ArticleId IdType="pmc">PMC7165999</ArticleId>
            <ArticleId IdType="pubmed">32313804</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Desforges M, Coupanec AL, Brison É, Meessen-Pinard M, Talbot PJ. Neuroinvasive and Neurotropic Human Respiratory Coronaviruses: Potential Neurovirulent Agents in Humans. Adv Exp Med Biol (2014) 807:75–96. 10.1007/978-81-322-1777-0_6
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-81-322-1777-0_6</ArticleId>
            <ArticleId IdType="pmc">PMC7121612</ArticleId>
            <ArticleId IdType="pubmed">24619619</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Desforges M, Le Coupanec A, Dubeau P, Bourgouin A, Lajoie L, Dubé M, et al. . Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? Viruses (2020) 12(1):14. 10.3390/v12010014
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/v12010014</ArticleId>
            <ArticleId IdType="pmc">PMC7020001</ArticleId>
            <ArticleId IdType="pubmed">31861926</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Arbour N, Day R, Newcombe J, Talbot PJ. Neuroinvasion by Human Respiratory Coronaviruses. J Virol (2000) 74:8913–21. 10.1128/JVI.74.19.8913-8921.2000
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JVI.74.19.8913-8921.2000</ArticleId>
            <ArticleId IdType="pmc">PMC102086</ArticleId>
            <ArticleId IdType="pubmed">10982334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Liu JM, Tan BH, Wu S, Gui Y, Suo JL, Li YC. Evidence of Central Nervous System Infection and Neuroinvasive Routes, as Well as Neurological Involvement, in the Lethality of SARS-CoV-2 Infection. J Med Virol (2021) 93(3):1304–13. 10.1002/jmv.26570
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jmv.26570</ArticleId>
            <ArticleId IdType="pmc">PMC7537172</ArticleId>
            <ArticleId IdType="pubmed">33002209</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Baig AM. Neurological Manifestations in COVID-19 Caused by SARS-CoV-2. CNS Neurosci Ther (2020) 26:499–501. 10.1111/cns.13372
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cns.13372</ArticleId>
            <ArticleId IdType="pmc">PMC7163592</ArticleId>
            <ArticleId IdType="pubmed">32266761</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Iroegbu JD, Ifenatuoha CW, Ijomone OM. Potential Neurological Impact of Coronaviruses: Implications for the Novel SARS-CoV-2. Neurol Sci (2020) 41:1329–37. 10.1007/s10072-020-04469-4
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10072-020-04469-4</ArticleId>
            <ArticleId IdType="pmc">PMC7232928</ArticleId>
            <ArticleId IdType="pubmed">32424503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Desforges M, Le Coupanec A, Stodola JK, Meessen-Pinard M, Talbot PJ. Human Coronaviruses: Viral and Cellular Factors Involved in Neuroinvasiveness and Neuropathogenesis. Virus Res (2014) 194:145–58. 10.1016/j.virusres.2014.09.011
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.virusres.2014.09.011</ArticleId>
            <ArticleId IdType="pmc">PMC7114389</ArticleId>
            <ArticleId IdType="pubmed">25281913</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Goés A, Cardoso BB, Tavares F, Monte R, Melo RC, Araújo-Neto I, et al. . COVID-19 and Nervous System: Under Estimated Clinical and Prognostic Aspects. Int J Neurol Neurotherapy (2020) 7:1–7. 10.23937/2378-3001/1410100
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.23937/2378-3001/1410100</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. . Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol (2020) 77:683–90. 10.1001/jamaneurol.2020.1127
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId>
            <ArticleId IdType="pmc">PMC7149362</ArticleId>
            <ArticleId IdType="pubmed">32275288</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Karadaş Ö, Öztürk B, Sonkaya AR. A Prospective Clinical Study of Detailed Neurological Manifestations in Patients With COVID-19. Neurol Sci (2020) 41:1991–5. 10.1007/s10072-020-04547-7
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10072-020-04547-7</ArticleId>
            <ArticleId IdType="pmc">PMC7316428</ArticleId>
            <ArticleId IdType="pubmed">32588367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Rifino N, Censori B, Agazzi E, Alimonti D, Bonito V, Camera G, et al. . Neurologic Manifestations in 1760 COVID-19 Patients Admitted to Papa Giovanni XXIII Hospital, Bergamo, Italy. J Neurol (2020) October:1–8. 10.1007/s00415-020-10251-5
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-020-10251-5</ArticleId>
            <ArticleId IdType="pmc">PMC7539268</ArticleId>
            <ArticleId IdType="pubmed">33026520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. . Clinical Characteristics of 113 Deceased Patients With Coronavirus Disease 2019: Retrospective Study. BMJ (2020) 368:1–14. 10.1136/bmj.m1091
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.m1091</ArticleId>
            <ArticleId IdType="pmc">PMC7190011</ArticleId>
            <ArticleId IdType="pubmed">32217556</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chuang DT, Aydemir S, Magda P, Thomas C, Zarnegar R. Neurological Manifestations as Primary Presentation of COVID-19 in Hospitalized Patients. Acta Neurol Scand (2021) 143(5):569–74. 10.1111/ane.13399
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ane.13399</ArticleId>
            <ArticleId IdType="pmc">PMC8014329</ArticleId>
            <ArticleId IdType="pubmed">33559885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yeh EA, Collins A, Cohen ME, Duffner PK, Faden H. Detection of Coronavirus in the Central Nervous System of a Child With Acute Disseminated Encephalomyelitis. Pediatrics (2004) 113:e72–e6. 10.1542/peds.113.1.e73
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1542/peds.113.1.e73</ArticleId>
            <ArticleId IdType="pubmed">14702500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Turgay C, Emine T, Ozlem K, Muhammet SP, Haydar AT. A Rare Cause of Acute Flaccid Paralysis: Human Coronaviruses. J Pediatr Neurosci (2015) 10:280–1. 10.4103/1817-1745.165716
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/1817-1745.165716</ArticleId>
            <ArticleId IdType="pmc">PMC4611905</ArticleId>
            <ArticleId IdType="pubmed">26557177</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sharma K, Tengsupakul S, Sanchez O, Phaltas R, Maertens P. Guillain–Barré Syndrome With Unilateral Peripheral Facial and Bulbar Palsy in a Child: A Case Report. SAGE Open Med Case Rep (2019) 7:1–5. 10.1177/2050313X19838750
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/2050313X19838750</ArticleId>
            <ArticleId IdType="pmc">PMC6429638</ArticleId>
            <ArticleId IdType="pubmed">30915222</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yamana M, Kuwahara M, Fukumoto Y, Yoshikawa K, Takada K, Kusunoki S. Guillain-Barré Syndrome and Related Diseases After Influenza Virus Infection. Neurol: Neuroimmunol Neuroinflamm (2019) 6:1–7. 10.1212/NXI.0000000000000575
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/NXI.0000000000000575</ArticleId>
            <ArticleId IdType="pmc">PMC6624088</ArticleId>
            <ArticleId IdType="pubmed">31355311</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Berciano J, Orizaola P, Gallardo E, Pelayo-Negro AL, Sánchez-Juan P, Infante J, et al. . Very Early Guillain-Barré Syndrome: A Clinical-Electrophysiological and Ultrasonographic Study. Clin Neurophysiol Pract (2020) 5:1–9. 10.1016/j.cnp.2019.11.003
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cnp.2019.11.003</ArticleId>
            <ArticleId IdType="pmc">PMC6923288</ArticleId>
            <ArticleId IdType="pubmed">31886449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Jasti AK, Selmi C, Sarmiento-Monroy JC, Vega DA, Anaya JM, Gershwin ME. Guillain-Barré Syndrome: Causes, Immunopathogenic Mechanisms and Treatment. Expert Rev Clin Immunol (2016) 12:1175–89. 10.1080/1744666X.2016.1193006
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/1744666X.2016.1193006</ArticleId>
            <ArticleId IdType="pubmed">27292311</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gittermann LMT, Feris SNV. Giacoman AvO. Relation Between COVID-19 and Guillain-Barré Syndrome in Adults: A Systematic Review. Neurología (English Edition) (2020) 35:646–54. 10.1016/j.nrleng.2020.07.005
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.nrleng.2020.07.005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kim JE, Heo JH, Kim HO, Song SH, Park SS, Park TH, et al. . Neurological Complications During Treatment of Middle East Respiratory Syndrome. J Clin Neurol (Korea) (2017) 13:227–33. 10.3988/jcn.2017.13.3.227
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3988/jcn.2017.13.3.227</ArticleId>
            <ArticleId IdType="pmc">PMC5532318</ArticleId>
            <ArticleId IdType="pubmed">28748673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Coen M, Jeansonc G, Almeidad LAC, Hübers A, Stierlin F, Najjar I, et al. . Guillain-Barré Syndrome as a Complication of SARS-CoV-2 Infection. Brain Behavior Immun J (2020) 87:111–2. 10.1016/j.bbi.2020.04.074
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbi.2020.04.074</ArticleId>
            <ArticleId IdType="pmc">PMC7194931</ArticleId>
            <ArticleId IdType="pubmed">32360440</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Camdessanche J-P, Morel J, Pozzetto B, Paul S, Tholance Y, Botelho-Nevers E. COVID-19 may Induce Guillain–Barré Syndrome. Rev Neurol (Paris) (2020) 176:516–20. 10.1016/j.neurol.2020.04.003
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neurol.2020.04.003</ArticleId>
            <ArticleId IdType="pmc">PMC7158797</ArticleId>
            <ArticleId IdType="pubmed">32334841</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sedaghat Z, Karimi N. Guillain Barre Syndrome Associated With COVID-19 Infection: A Case Report. J Clin Neurosci (2020) 76:233–5. 10.1016/j.jocn.2020.04.062
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jocn.2020.04.062</ArticleId>
            <ArticleId IdType="pmc">PMC7158817</ArticleId>
            <ArticleId IdType="pubmed">32312628</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Padroni M, Mastrangelo V, Asioli GM, Pavolucci L, Abu-Rumeileh S, Piscaglia MG, et al. . Guillain-Barré Syndrome Following COVID-19: New Infection, Old Complication? J Neurol (2020) 267:1877–9. 10.1007/s00415-020-09849-6
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-020-09849-6</ArticleId>
            <ArticleId IdType="pmc">PMC7180646</ArticleId>
            <ArticleId IdType="pubmed">32333166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Khalifa M, Zakaria F, Ragab Y, Saad A, Bamaga A, Emad Y, et al. . Guillain-Barré Syndrome Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Detection and Coronavirus Disease 2019 in a Child. J Pediatr Infect Dis Soc (2020) 9:510–3. 10.1093/jpids/piaa086
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jpids/piaa086</ArticleId>
            <ArticleId IdType="pmc">PMC7454732</ArticleId>
            <ArticleId IdType="pubmed">32652520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Alberti P, Beretta S, Piatti M, Karantzoulis A, Piatti ML, Santoro P, et al. . Guillain-Barré Syndrome Related to COVID-19 Infection. Neurol: Neuroimmunol Neuroinflamm (2020) 7(4):e741. 10.1212/NXI.0000000000000741
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/NXI.0000000000000741</ArticleId>
            <ArticleId IdType="pmc">PMC7217652</ArticleId>
            <ArticleId IdType="pubmed">32350026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, et al. . Vasoactive Intestinal Peptide in Checkpoint Inhibitor–Induced Pneumonitis. N Engl J Med (2020) 382:2573–4. 10.1056/NEJMc2000343
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMc2000343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Filosto M, Piccinelli SC, Gazzina S, Foresti C, Frigeni B, Servalli MC, et al. . Guillain-Barré Syndrome and COVID-19: An Observational Multicentre Study From Two Italian Hotspot Regions. J Neurol Neurosurg Psychiatry (2020) 324837. 10.1136/jnnp-2020-324837
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp-2020-324837</ArticleId>
            <ArticleId IdType="pmc">PMC7650204</ArticleId>
            <ArticleId IdType="pubmed">33158914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Dufour C, Co T-K, Liu A. Gm1 Ganglioside Antibody and COVID-19 Related Guillain Barre Syndrome–a Case Report, Systemic Review and Implication for Vaccine Development. Brain behavior Immunity Health (2021) 12:100203. 10.1016/j.bbih.2021.100203
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbih.2021.100203</ArticleId>
            <ArticleId IdType="pmc">PMC7805391</ArticleId>
            <ArticleId IdType="pubmed">33462567</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Tekin AB, Zanapalioglu U, Gulmez S, Akarsu I, Yassa M, Tug N. Guillain Barre Syndrome Following Delivery in a Pregnant Woman Infected With SARS-Cov-2. J Clin Neurosci (2021) 86:190–2. 10.1016/j.jocn.2021.01.028
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jocn.2021.01.028</ArticleId>
            <ArticleId IdType="pmc">PMC7993757</ArticleId>
            <ArticleId IdType="pubmed">33775326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Raahimi MM, Kane A, Moore CE, Alareed AW. Late Onset of Guillain-Barré Syndrome Following SARS-CoV-2 Infection: Part of ‘Long COVID-19 Syndrome’? BMJ Case Rep CP (2021) 14(1):e240178. 10.1136/bcr-2020-240178
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bcr-2020-240178</ArticleId>
            <ArticleId IdType="pmc">PMC7813388</ArticleId>
            <ArticleId IdType="pubmed">33462068</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré Syndrome Associated With SARS-CoV-2 Infection: Causality or Coincidence? Lancet Neurol (2020) 19:383–4. 10.1016/S1474-4422(20)30109-5
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1474-4422(20)30109-5</ArticleId>
            <ArticleId IdType="pmc">PMC7176927</ArticleId>
            <ArticleId IdType="pubmed">32246917</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ottaviani D, Boso F, Tranquillini E, Gapeni I, Pedrotti G, Cozzio S, et al. . Early Guillain-Barré Syndrome in Coronavirus Disease 2019 (COVID-19): A Case Report From an Italian COVID-Hospital. Neurol Sci (2020) 41:1351–4. 10.1007/s10072-020-04449-8
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10072-020-04449-8</ArticleId>
            <ArticleId IdType="pmc">PMC7216127</ArticleId>
            <ArticleId IdType="pubmed">32399950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bastug A, Bektas H, Buyuktarakci C, Bodur H. Parainfectious Guillain Barre Syndrome in a Patient Diagnosed With COVID-19. Res Square (2021). 10.21203/rs.3.rs-215097/v1
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.21203/rs.3.rs-215097/v1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Khalifa M, Zakaria F, Ragab Y, Saad A, Bamaga A, Emad Y, et al. . Guillain-Barré Syndrome Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Detection and Coronavirus Disease 2019 in a Child. J Pediatr Infect Dis Soc (2020) 9(4):510–3. 10.1093/jpids/piaa086
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jpids/piaa086</ArticleId>
            <ArticleId IdType="pmc">PMC7454732</ArticleId>
            <ArticleId IdType="pubmed">32652520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mancera-Páez O, Román GC, Pardo-Turriago R, Rodríguez Y, Anaya JM. Concurrent Guillain-Barré Syndrome, Transverse Myelitis and Encephalitis Post-Zika: A Case Report and Review of the Pathogenic Role of Multiple Arboviral Immunity. J Neurol Sci (2018) 395:47–53. 10.1016/j.jns.2018.09.028
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2018.09.028</ArticleId>
            <ArticleId IdType="pubmed">30292020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hussain FS, Eldeeb MA, Blackmore D, Siddiqi ZA. Guillian Barré Syndrome and COVID-19: Possible Role of the Cytokine Storm. Autoimmun Rev (2020) 19(12):102681. 10.1016/j.autrev.2020.102681
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.autrev.2020.102681</ArticleId>
            <ArticleId IdType="pmc">PMC7577871</ArticleId>
            <ArticleId IdType="pubmed">33099040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré Syndrome. Lancet (2016) 388:717–27. 10.1016/S0140-6736(16)00339-1
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(16)00339-1</ArticleId>
            <ArticleId IdType="pubmed">26948435</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ang CW, Jacobs BC, Brandenburg AH, Laman JD, Van Der Meché FGA, Osterhaus ADME, et al. . Cross-Reactive Antibodies Against GM2 and CMV-infected Fibroblasts in Guillain-Barre Syndrome. Neurology (2000) 54:1453–8. 10.1212/WNL.54.7.1453
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.54.7.1453</ArticleId>
            <ArticleId IdType="pubmed">10751257</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Rodríguez Y, Rojas M, Pacheco Y, Acosta-Ampudia Y, Ramírez-Santana C, Monsalve DM, et al. . Guillain–Barré Syndrome, Transverse Myelitis and Infectious Diseases. Cell Mol Immunol (2018) 15:547–62. 10.1038/cmi.2017.142
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/cmi.2017.142</ArticleId>
            <ArticleId IdType="pmc">PMC6079071</ArticleId>
            <ArticleId IdType="pubmed">29375121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Islam B, Islam Z, Geurtsvankessel CH, Jahan I, Endtz HP, Mohammad QD, et al. . Guillain-Barré Syndrome Following Varicella-Zoster Virus Infection. Eur J Clin Microbiol Infect Dis (2018) 37:511–8. 10.1007/s10096-018-3199-5
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10096-018-3199-5</ArticleId>
            <ArticleId IdType="pubmed">29411189</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Goodfellow JA, Willison HJ. Guillain-Barré Syndrome: A Century of Progress. Nat Rev Neurol (2016) 12:723–31. 10.1038/nrneurol.2016.172
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrneurol.2016.172</ArticleId>
            <ArticleId IdType="pubmed">27857121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kim SY, Choe KW, Park S, Yoon D, Ock CY, Hong SW, et al. . Mild Form of Guillain-Barré Syndrome in a Patient With Primary Epstein-Barr Virus Infection. Korean J Intern Med (2016) 31:1191–3. 10.3904/kjim.2015.033
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3904/kjim.2015.033</ArticleId>
            <ArticleId IdType="pmc">PMC5094921</ArticleId>
            <ArticleId IdType="pubmed">26837010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Jacobs BC, Rothbarth PH, FGAvd M, Herbrink P, Schmitz PIM, Klerk M, et al. . The Spectrum of Antecedent Infections in Guillain-Barré Syndrome. Neurology (1998) 51:1110–5. 10.1212/WNL.51.4.1110
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.51.4.1110</ArticleId>
            <ArticleId IdType="pubmed">9781538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chroni E, Thomopoulos C, Papapetropoulos S, Paschalis C, Karatza CL. A Case of Relapsing Guillain-Barré Syndrome Associated With Exacerbation of Chronic Hepatitis B Virus Hepatitis. J Neurovirol (2003) 9:408–10. 10.1080/13550280390201731
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/13550280390201731</ArticleId>
            <ArticleId IdType="pubmed">12775424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ray G, Ghosh B, Bhattacharyya R. Acute Hepatitis B Presenting as Guillain-Barré Syndrome. Indian J Gastroenterol (2003) 22:228–30.</Citation>
        </Reference>
        <Reference>
          <Citation>
Yimam KK, Merriman RB, Frederick RT. A Rare Case of Acute Hepatitis B Virus Infection Causing Guillain-Barré Syndrome. Gastroenterol Hepatol (2013) 9:121–3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3754771</ArticleId>
            <ArticleId IdType="pubmed">23983658</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sonavane AD, Saigal S, Kathuria A, Choudhary NS, Saraf N. Guillain–Barré Syndrome: Rare Extra-Intestinal Manifestation of Hepatitis B. Clin J Gastroenterol (2018) 11:312–4. 10.1007/s12328-018-0847-3
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12328-018-0847-3</ArticleId>
            <ArticleId IdType="pubmed">29542024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mardani M, Khodashahi R, Faghani Y. Guillain-Barre Syndrome Associated With Acute Hepatitis A: A Case Report. Asian J Case Rep Med Health (2020) 3:21–5.</Citation>
        </Reference>
        <Reference>
          <Citation>
Sivadon-Tardy V, Orlikowski D, Porcher R, Sharshar T, Durand MC, Enouf V, et al. . Guillain-Barré Syndrome and Influenza Virus Infection. Clin Infect Dis (2009) 48:48–56. 10.1086/594124
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/594124</ArticleId>
            <ArticleId IdType="pubmed">19025491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Steininger C, Seiser A, Gueler N, Puchhammer-Stöckl E, Aberle SW, Stanek G, et al. . Primary Cytomegalovirus Infection in Patients With Guillain-Barré Syndrome. J Neuroimmunol (2007) 183:214–9. 10.1016/j.jneuroim.2006.11.006
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2006.11.006</ArticleId>
            <ArticleId IdType="pubmed">17184845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kennedy M, Apostolova M. A Rare Case of Infectious Mononucleosis Complicated by Guillain-Barre Syndrome. Neurol Int (2013) 5:20–2. 10.4081/ni.2013.e7
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4081/ni.2013.e7</ArticleId>
            <ArticleId IdType="pmc">PMC3718247</ArticleId>
            <ArticleId IdType="pubmed">23888210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Van Den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, Van Doorn PA. Guillain-Barré Syndrome: Pathogenesis, Diagnosis, Treatment and Prognosis. Nat Rev Neurol (2014) 10:469–82. 10.1038/nrneurol.2014.121
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrneurol.2014.121</ArticleId>
            <ArticleId IdType="pubmed">25023340</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Loshaj-Shala A, Regazzoni L, Daci A, Orioli M, Brezovska K, Panovska AP, et al. . Guillain Barré Syndrome (GBS): New Insights in the Molecular Mimicry Between C. Jejuni and Human Peripheral Nerve (HPN) Proteins. J Neuroimmunol (2015) 289:168–76. 10.1016/j.jneuroim.2015.11.005
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2015.11.005</ArticleId>
            <ArticleId IdType="pubmed">26616887</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yuki N. Infectious Origins of, and Molecular Mimicry in Guillain-Barré and Fisher Syndromes. Lancet Infect Dis (2001) 1:29–37. 10.1016/S1473-3099(01)00019-6
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1473-3099(01)00019-6</ArticleId>
            <ArticleId IdType="pubmed">11871407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Susuki K, Rasband MN, Tohyama K, Koibuchi K, Okamoto S, Funakoshi K, et al. . Anti-GM1 Antibodies Cause Complement-Mediated Disruption of Sodium Channel Clusters in Peripheral Motor Nerve Fibers. J Neurosci (2007) 27:3956–67. 10.1523/JNEUROSCI.4401-06.2007
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.4401-06.2007</ArticleId>
            <ArticleId IdType="pmc">PMC6672537</ArticleId>
            <ArticleId IdType="pubmed">17428969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Irie S, Saito T, Nakamura K, Kanazawa N, Ogino M, Nukazawa T, et al. . Association of anti-GM2 Antibodies in Guillain-Barre Syndrome With Acute Cytomegalovirus Infection. J Neuroimmunol (1996) 68:19–26. 10.1016/0165-5728(96)00059-8
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0165-5728(96)00059-8</ArticleId>
            <ArticleId IdType="pubmed">8784256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Jacobs BC, Van Doorn PA, Groeneveld JHM, Tio-Gillen AP, Van Der Meché FGA. Cytomegalovirus Infections and anti-GM2 Antibodies in Guillain-Barré Syndrome. J Neurol Neurosurg Psychiatry (1997) 62:641–3. 10.1136/jnnp.62.6.641
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp.62.6.641</ArticleId>
            <ArticleId IdType="pmc">PMC1074154</ArticleId>
            <ArticleId IdType="pubmed">9219756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Loly JP, Rikir E, Seivert M, Legros E, Defrance P, Belaiche J, et al. . Guillain-Barré Syndrome Following Hepatitis E. World J Gastroenterol (2009) 15:1645–7. 10.3748/wjg.15.1645
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3748/wjg.15.1645</ArticleId>
            <ArticleId IdType="pmc">PMC2669950</ArticleId>
            <ArticleId IdType="pubmed">19340910</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Nascimento OJM, Da Silva IRF. Guillain-Barré Syndrome and Zika Virus Outbreaks. Curr Opin Neurol (2017) 30:500–7. 10.1097/WCO.0000000000000471
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/WCO.0000000000000471</ArticleId>
            <ArticleId IdType="pubmed">28617719</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Brito Ferreira ML, Militão de Albuquerque M, de Brito CAA, de Oliveira França RF, Porto Moreira ÁJ, de Morais Machado MÍ, et al. . Neurological Disease in Adults With Zika and Chikungunya Virus Infection in Northeast Brazil: A Prospective Observational Study. Lancet Neurol (2020) 19:826–39. 10.1016/S1474-4422(20)30232-5
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1474-4422(20)30232-5</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Smith DW, Mackenzie J. Zika Virus and Guillain-Barré Syndrome: Another Viral Cause to Add to the List. Lancet (2016) 387:1486–8. 10.1016/S0140-6736(16)00564-X
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(16)00564-X</ArticleId>
            <ArticleId IdType="pubmed">26948432</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Walteros DM, Soares J, Styczynski AR, Abrams JY, Galindo-Buitrago JI, Acosta-Reyes J, et al. . Long-Term Outcomes of Guillain-Barré Syndrome Possibly Associated With Zika Virus Infection. PloS One (2019) 14:1–14. 10.1371/journal.pone.0220049
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0220049</ArticleId>
            <ArticleId IdType="pmc">PMC6675241</ArticleId>
            <ArticleId IdType="pubmed">31369576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Stegmann-Planchard S, Gallian P, Tressières B, Leparc-Goffart I, Lannuzel A, Signaté A, et al. . Chikungunya, a Risk Factor for Guillain-Barré Syndrome. Clin Infect Dis (2020) 70:1233–5. 10.1093/cid/ciz625
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/ciz625</ArticleId>
            <ArticleId IdType="pubmed">31290540</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Rosário M, Jesus P, Vasilakis N, Farias DS, Novaes MAC, Rodrigues SG, et al. . Case Report: Guillain-barré Syndrome After Zika Virus Infection in Brazil. Am J Trop Med Hyg (2016) 95:1157–60. 10.4269/ajtmh.16-0306
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4269/ajtmh.16-0306</ArticleId>
            <ArticleId IdType="pmc">PMC5094232</ArticleId>
            <ArticleId IdType="pubmed">27645785</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cao-Lormeau VM, Blake A, Mons S, Lastère S, Roche C, Vanhomwegen J, et al. . Guillain-Barré Syndrome Outbreak Associated With Zika Virus Infection in French Polynesia: A Case-Control Study. Lancet (2016) 387:1531–9. 10.1016/S0140-6736(16)00562-6
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(16)00562-6</ArticleId>
            <ArticleId IdType="pmc">PMC5444521</ArticleId>
            <ArticleId IdType="pubmed">26948433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Santos TD, Rodriguez A, Almiron M, Sanhueza A, Ramon P, Oliveira W, et al. . Zika Virus and the Guillain–Barré Syndrome — Case Series From Seven Countries. New Engl J Med (2016) 375:1598–601. 10.1056/NEJMc1609015
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMc1609015</ArticleId>
            <ArticleId IdType="pubmed">27579558</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Rivera-Correa J, De Siqueira IC, Mota S, Do Rosário MS, De Jesus PAP, Carlos L, Jr, et al. . Anti-Ganglioside Antibodies in Patients With Zika Virus Infection-Associated Guillain-BarréSyndrome in Brazil. PloS Negl Trop Dis (2019) 13:1–13. 10.1371/journal.pntd.0007695
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pntd.0007695</ArticleId>
            <ArticleId IdType="pmc">PMC6764688</ArticleId>
            <ArticleId IdType="pubmed">31527907</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Baskar D, Amalnath D, Mandal J, Dhodapkar R, Vanathi K. Antibodies to Zika Virus, Campylobacter Jejuni and Gangliosides in Guillain-Barre Syndrome: A Prospective Single-Center Study From Southern India. Neurol India (2018) 66:1324–31. 10.4103/0028-3886.241402
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/0028-3886.241402</ArticleId>
            <ArticleId IdType="pubmed">30232998</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Siu R, Bukhari W, Todd A, Gunn W, Huang QS, Timmings P. Acute Zika Inection With Concurrent Onset of Guillain-Barré Syndrome. Neurology (2016) 87:1623–4. 10.1212/WNL.0000000000003038
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000003038</ArticleId>
            <ArticleId IdType="pubmed">27466468</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mancera-Páez O, Román GC, Pardo-Turriago R, Rodríguez Y, Anaya J-M. Concurrent Guillain-Barré Syndrome, Transverse Myelitis and Encephalitis Post-Zika: A Case Report and Review of the Pathogenic Role of Multiple Arboviral Immunity. J Neurol Sci (2018) 395:47–53. 10.1016/j.jns.2018.09.028
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2018.09.028</ArticleId>
            <ArticleId IdType="pubmed">30292020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Munhoz RP, Pedroso JL, Nascimento FA, De Almeida SM, Barsottini OGP, Cardoso FEC, et al. . Neurological Complications in Patients With SARS-CoV-2 Infection: A Systematic Review. Arq Neuropsiquiatr (2020) 78:290–300. 10.1590/0004-282x20200051
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/0004-282x20200051</ArticleId>
            <ArticleId IdType="pubmed">32490966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cappello F, Marino Gammazza A, Dieli F, Conway de Macario E, Macario AJ. Does SARS-CoV-2 Trigger Stress-Induced Autoimmunity by Molecular Mimicry? A Hypothesis J Clin Med (2020) 9:2038. 10.3390/jcm9072038
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/jcm9072038</ArticleId>
            <ArticleId IdType="pmc">PMC7408943</ArticleId>
            <ArticleId IdType="pubmed">32610587</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lucchese G, Kanduc D. Zika Virus and Autoimmunity: From Microcephaly to Guillain-Barré Syndrome, and Beyond. Autoimmun Rev (2016) 15:801–8. 10.1016/j.autrev.2016.03.020
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.autrev.2016.03.020</ArticleId>
            <ArticleId IdType="pubmed">27019049</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lucchese G, Flöel A. Sars-CoV-2 and Guillain-Barré Syndrome: Molecular Mimicry With Human Heat Shock Proteins as Potential Pathogenic Mechanism. Cell Stress Chaperones (2020) 25:731–5. 10.1007/s12192-020-01145-6
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12192-020-01145-6</ArticleId>
            <ArticleId IdType="pmc">PMC7387880</ArticleId>
            <ArticleId IdType="pubmed">32729001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Needham EJ, Chou SHY, Coles AJ, Menon DK. Neurological Implications of COVID-19 Infections. Neurocrit Care (2020) 32:667–71. 10.1007/s12028-020-00978-4
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12028-020-00978-4</ArticleId>
            <ArticleId IdType="pmc">PMC7188454</ArticleId>
            <ArticleId IdType="pubmed">32346843</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Moudgil KD, Thompson SJ, Geraci F, De Paepe B, Shoenfeld Y. Heat-Shock Proteins in Autoimmunity. Autoimmune Dis (2013) 2013:1–3. 10.1155/2013/621417
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2013/621417</ArticleId>
            <ArticleId IdType="pmc">PMC3671508</ArticleId>
            <ArticleId IdType="pubmed">23762533</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chiba S, Yokota SI, Yonekura K, Tanaka S, Furuyama H, Kubota H, et al. . Autoantibodies Against HSP70 Family Proteins Were Detected in the Cerebrospinal Fluid From Patients With Multiple Sclerosis. J Neurol Sci (2006) 241:39–43. 10.1016/j.jns.2005.10.009
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2005.10.009</ArticleId>
            <ArticleId IdType="pubmed">16303141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Prabhakar S, Kurien E, Gupta RS, Zielinski S, Freedman MS. Heat Shock Protein Immunoreactivity in CSF Correlation With Oligoclonal Banding and Demyelinating Disease. Neurology (1994) 44(9):1644. 10.1212/WNL.44.9.1644
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.44.9.1644</ArticleId>
            <ArticleId IdType="pubmed">7936289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Romi F, Helgeland G, Gilhus NE. Heat-Shock Proteins in Clinical Neurology. Eur Neurol (2011) 66:65–9. 10.1159/000329373
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000329373</ArticleId>
            <ArticleId IdType="pubmed">21757921</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Helgeland G, Petzold A, Hoff JM, Gilhus NE, Plant GT, Romi FR. Anti-Heat Shock Protein 70 Antibody Levels are Increased in Myasthenia Gravis and Guillain-Barré Syndrome. J Neuroimmunol (2010) 225:180–3. 10.1016/j.jneuroim.2010.04.024
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2010.04.024</ArticleId>
            <ArticleId IdType="pubmed">20554026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yonekura K, Yokota SI, Tanaka S, Kubota H, Fujii N, Matsumoto H, et al. . Prevalence of Anti-Heat Shock Protein Antibodies in Cerebrospinal Fluids of Patients With Guillain-Barré Syndrome. J Neuroimmunol (2004) 156:204–9. 10.1016/j.jneuroim.2004.07.017
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2004.07.017</ArticleId>
            <ArticleId IdType="pubmed">15465612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hart IK, Kennedy PG. Guillain-Barré Syndrome Associated With Cytomegalovirus Infection. QJM (1988) 67:425–30. 10.1093/oxfordjournals.qjmed.a068208
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/oxfordjournals.qjmed.a068208</ArticleId>
            <ArticleId IdType="pubmed">2851853</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zhang H-L, Zheng X-Y, Zhu J. Th1/Th2/Th17/Treg Cytokines in Guillain–Barré Syndrome and Experimental Autoimmune Neuritis. Cytokine Growth Factor Rev (2013) 24(5):443–53. 10.1016/j.cytogfr.2013.05.005
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cytogfr.2013.05.005</ArticleId>
            <ArticleId IdType="pubmed">23791985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hohnoki K, Inoue A, Koh C-S. Elevated Serum Levels of IFN-γ, IL-4 and TNF-α/Unelevated Serum Levels of IL-10 in Patients With Demyelinating Diseases During the Acute Stage. J Neuroimmunol (1998) 87(1-2):27–32. 10.1016/S0165-5728(98)00053-8
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0165-5728(98)00053-8</ArticleId>
            <ArticleId IdType="pubmed">9670842</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Li S, Yu M, Li H, Zhang H, Jiang Y. Il-17 and IL-22 in Cerebrospinal Fluid and Plasma are Elevated in Guillain-Barre Syndrome. Mediators Inflamm (2012) 2012:260473. 10.1155/2012/260473
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2012/260473</ArticleId>
            <ArticleId IdType="pmc">PMC3468147</ArticleId>
            <ArticleId IdType="pubmed">23091305</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Maddur MS, Rabin M, Hegde P, Bolgert F, Guy M, Vallat J-M, et al. . Intravenous Immunoglobulin Exerts Reciprocal Regulation of Th1/Th17 Cells and Regulatory T Cells in Guillain–Barré Syndrome Patients. Immunol Res (2014) 60(2):320–9. 10.1007/s12026-014-8580-6
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12026-014-8580-6</ArticleId>
            <ArticleId IdType="pubmed">25391612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Thepmankorn P, Bach J, Lasfar A, Zhao X, Souayah S, Chong ZZ, et al. . Cytokine Storm Induced by SARS-CoV-2 Infection: The Spectrum of its Neurological Manifestations. Cytokine (2020) 138:155404. 10.1016/j.cyto.2020.155404
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cyto.2020.155404</ArticleId>
            <ArticleId IdType="pmc">PMC7832981</ArticleId>
            <ArticleId IdType="pubmed">33360025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Garcia MA, Barreras PV, Lewis A, Pinilla G, Sokoll LJ, Kickler T, et al. . Cerebrospinal Fluid in COVID-19 Neurological Complications: No Cytokine Storm or Neuroinflammation. medRxiv (2021). 10.1101/2021.01.10.20249014
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/2021.01.10.20249014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Jasti AK, Selmi C, Sarmiento-Monroy JC, Vega DA, Anaya J-M, Gershwin ME. Guillain-Barré Syndrome: Causes, Immunopathogenic Mechanisms and Treatment. Expert Rev Clin Immunol (2016) 12(11):1175–89. 10.1080/1744666X.2016.1193006
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/1744666X.2016.1193006</ArticleId>
            <ArticleId IdType="pubmed">27292311</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
